Los Angeles Capital Management LLC Beam Therapeutics Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.7 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
SELL
$21.22 - $32.66 $23,448 - $36,089
-1,105 Reduced 6.18%
16,787 $393,000
Q4 2023

Feb 06, 2024
SELL
$17.69 - $30.76 $121,583 - $211,413
-6,873 Reduced 27.75%
17,892 $487,000
Q3 2023

Nov 06, 2023
SELL
$23.01 - $32.46 $47,952 - $67,646
-2,084 Reduced 7.76%
24,765 $595,000
Q2 2023

Aug 03, 2023
BUY
$29.32 - $35.99 $126,105 - $154,792
4,301 Added 19.07%
26,849 $857,000
Q1 2023

May 04, 2023
SELL
$30.15 - $48.79 $72,661 - $117,583
-2,410 Reduced 9.66%
22,548 $690,000
Q4 2022

Feb 06, 2023
BUY
$36.73 - $51.6 $279,184 - $392,211
7,601 Added 43.79%
24,958 $976,000
Q3 2022

Nov 02, 2022
BUY
$39.79 - $70.31 $34,259 - $60,536
861 Added 5.22%
17,357 $827,000
Q2 2022

Aug 05, 2022
BUY
$29.86 - $62.36 $125,382 - $261,849
4,199 Added 34.15%
16,496 $639,000
Q1 2022

May 06, 2022
BUY
$53.73 - $82.16 $225,666 - $345,072
4,200 Added 51.87%
12,297 $705,000
Q4 2021

Feb 03, 2022
SELL
$68.02 - $99.06 $7,210 - $10,500
-106 Reduced 1.29%
8,097 $645,000
Q2 2021

Aug 05, 2021
SELL
$64.12 - $128.71 $14,106 - $28,316
-220 Reduced 2.61%
8,203 $1.06 Million
Q1 2021

May 05, 2021
BUY
$71.28 - $120.75 $600,391 - $1.02 Million
8,423 New
8,423 $674,000

Others Institutions Holding BEAM

# of Institutions
232
Shares Held
75.3M
Call Options Held
392K
Put Options Held
202K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.69B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email